Opioid overdose is a leading public health problem across Canada that continues to evolve, particularly as clandestinely-produced opioids enter the market (Public Health Agency of Canada, 2017). In 2014, we published a study that found that...
Main points In 2016, there were 64 deaths related to volatile substances registered in Great Britain; over 80% of these volatile substance abuse (VSA) deaths were males. There were 834 deaths involving volatile substances registered between...
Abstract Background The US is experiencing an unprecedented opioid overdose epidemic fostered in recent years by regional contamination of the heroin supply with the fentanyl family of synthetic opioids. Since 2011 opioid-related overdose...
Abstract Background: Annually, 600 000 deaths are attributed to exposure of non-smokers to secondhand smoke (SHS). These include 165 000 among children, about 60% of which occur in Africa and Southeast Asia. As of 2017, only seven countries...
Effectiveness Bank Analysis: Keep Maintaining Opiate-Dependent Prisoners From the USA, a rare randomised trial found in favour of continuing methadone maintenance when patients entered prison rather than compulsory withdrawal. The potential...
Abstract [ABSTRACT]. Objective: To analyze trends in mortality due to diseases and conditions fully attributable to alcohol in Brazil. Methods: This was an ecological time-series study. Proportional, specific, and age-standardized mortality...
Key Points Question: What is the association of cigar, pipe, and cigarette use with mortality risk in the US population? Findings: In this nationally representative longitudinal cohort study of 357 420 participants comparing exclusive cigar...
Trials challenge the need for the widely accepted policy of making opioid-dependent patients take their methadone or other opioid substitutes at the clinic or pharmacy, but ‘no difference’ findings may be due to the limitations of the...
Based on research, financial data and stakeholder surveys and testimonies, the UK government’s official drug policy advisers warn that without significant efforts to protect investment and quality, in England “loss of funding will result in...